These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29271613)

  • 1. Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea.
    Kim TY; Shong YK
    Endocrinol Metab (Seoul); 2017 Dec; 32(4):399-406. PubMed ID: 29271613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active Surveillance of Papillary Thyroid Microcarcinoma: Where Do We Stand?
    Jeon MJ; Kim WG; Chung KW; Baek JH; Kim WB; Shong YK
    Eur Thyroid J; 2019 Dec; 8(6):298-306. PubMed ID: 31934555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Surveillance of Thyroid Microcarcinoma-Can This Approach Be Safely Implemented Worldwide?
    Pollack R; Mazeh H
    J Surg Res; 2021 Feb; 258():145-152. PubMed ID: 33010560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Active Surveillance be an Alternative to Surgery in Papillary Thyroid Microcarcinoma?: The Current Situation Worldwide.
    Aygün N; İşgör A; Uludağ M
    Sisli Etfal Hastan Tip Bul; 2018; 52(4):233-243. PubMed ID: 32774084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
    Soares P; Celestino R; Gaspar da Rocha A; Sobrinho-Simões M
    Int J Surg Pathol; 2014 Apr; 22(2):113-9. PubMed ID: 24401191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
    Kim K; Choi JY; Kim SJ; Lee EK; Lee YK; Ryu JS; Lee KE; Moon JH; Park YJ; Cho SW; Park SK
    Thyroid; 2022 Jun; 32(6):648-656. PubMed ID: 35570657
    [No Abstract]   [Full Text] [Related]  

  • 7. Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects.
    Xue S; Wang P; Hurst ZA; Chang YS; Chen G
    Front Endocrinol (Lausanne); 2018; 9():736. PubMed ID: 30619082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).
    Moon JH; Kim JH; Lee EK; Lee KE; Kong SH; Kim YK; Jung WJ; Lee CY; Yoo RE; Hwangbo Y; Song YS; Kim MJ; Cho SW; Kim SJ; Jung EJ; Choi JY; Ryu CH; Lee YJ; Hah JH; Jung YS; Ryu J; Hwang Y; Park SK; Sung HK; Yi KH; Park DJ; Park YJ
    Endocrinol Metab (Seoul); 2018 Jun; 33(2):278-286. PubMed ID: 29947183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rising incidence of papillary thyroid microcarcinoma and is completion surgery necessary or not?
    Kuşcu O; Önay Ö; Kayahan B; Süslü N; Yılmaz T
    Otolaryngol Pol; 2016 Jun; 70(0):14-8. PubMed ID: 27383733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rising incidence of papillary thyroid microcarcinoma and is completion surgery necessary or not?
    Kuşcu O; Önay Ö; Kayahan B; Süslü N; Yılmaz T
    Otolaryngol Pol; 2016 Jun; 70(3):15-9. PubMed ID: 27386928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance for low-risk small papillary thyroid cancer in North American countries: past, present and future (bridging the gap between North American and Asian practices).
    Pusztaszeri MP; Tamilia M; Payne RJ
    Gland Surg; 2020 Oct; 9(5):1685-1697. PubMed ID: 33224846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
    Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
    Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma.
    Lim DJ; Baek KH; Lee YS; Park WC; Kim MK; Kang MI; Jeon HM; Lee JM; Yun-Cha B; Lee KW; Son HY; Kang SK
    Thyroid; 2007 Sep; 17(9):883-8. PubMed ID: 17956162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance.
    Hirokawa M; Kudo T; Ota H; Suzuki A; Miyauchi A
    Endocr J; 2016 Sep; 63(9):805-810. PubMed ID: 27397594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
    Roti E; Rossi R; Trasforini G; Bertelli F; Ambrosio MR; Busutti L; Pearce EN; Braverman LE; Degli Uberti EC
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2171-8. PubMed ID: 16478817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients.
    Qian K; Guo K; Zheng X; Sun T; Li D; Wu Y; Ji Q; Wang Z
    Oncotarget; 2017 Sep; 8(39):65836-65846. PubMed ID: 29029476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
    Brito JP; Ito Y; Miyauchi A; Tuttle RM
    Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal ablation for papillary thyroid microcarcinoma: Some clarity amid controversies.
    Yue W; Wang S; Xu H
    J Interv Med; 2022 Nov; 5(4):171-172. PubMed ID: 36532304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new paradigm in low-risk papillary microcarcinoma: active surveillance.
    González Bóssolo A; Garcia MM; González PJ; Garcia M; Villarmarzo G; Martinez JH
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28924477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.